Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

PERNIX THERAPEUTICS HOLDINGS, INC. (PTX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-18Jun-30-18Mar-31-18Dec-31-17Sep-30-17Jun-30-17Mar-31-17Dec-31-16
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Total revenues  127.9131.2144.5146.1134.7135.7138.1115.2
            Revenue growth  -5.0%-3.3%4.6%26.8%-44.3%-45.5%-46.7%-59.7%
Cost of goods sold  39.938.643.644.640.240.442.143.3
Gross profit  88.192.6100.9101.494.595.396.071.9
            Gross margin  68.8%70.6%69.9%69.4%70.2%70.2%69.5%62.4%
Selling, general and administrative   [+]136.8129.8146.3157.9203.1222.2232.6218.8
Other operating expenses     -0.3   7.8
EBITDA   [+]-89.4-62.0-53.4-55.7-127.2-98.9-101.8-109.3
            EBITDA margin  -69.8%-47.2%-37.0%-38.2%-94.4%-72.9%-73.7%-94.9%
Depreciation  0.40.40.40.40.40.921.945.4
EBITA  -89.8-62.3-53.8-56.1-127.6-99.8-123.6-154.7
            EBITA margin  -70.2%-47.5%-37.2%-38.4%-94.7%-73.5%-89.5%-134.3%
Amortization of intangibles  -41.3-25.5-8.70.0-10.136.618.50.0
EBIT   [+]-48.4-36.9-45.1-56.1-117.5-136.4-142.1-154.7
            EBIT margin  -37.9%-28.1%-31.2%-38.4%-87.2%-100.5%-102.9%-134.3%
Non-recurring items   [+]   0.3   -5.5
Other income (expense), net  -36.7-20.6-20.5-20.3-21.7-36.1-36.0-19.9
Pre-tax income  -85.5-57.8-65.9-76.8-130.3-163.1-172.7-169.2
Income taxes  0.40.30.40.40.50.50.50.4
            Tax rate      -0.4%   
Net income  32.851.051.051.089.957.125.90.0
            Net margin  25.7%38.9%35.3%34.9%66.7%42.1%18.8%0.0%
   
Basic EPS   [+]$2.75$4.48$4.67$4.88$9.22$6.22$3.11$0.00
Diluted EPS   [+]$2.75$4.00$4.16$4.32$8.10$6.22$3.11$0.00
   
   
Shares outstanding (basic)   [+]11.911.410.910.59.79.28.37.4
Shares outstanding (diluted)   [+]11.912.812.311.811.19.28.37.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy